Literature DB >> 15596021

Protein kinase C in cardiac disease and as a potential therapeutic target.

Stephen Murphy1, William H Frishman.   

Abstract

Protein kinase C (PKC) is a member of a large family of serine/threonine kinases that plays an integral role in many of the signaling cascades that govern cellular behavior. As such, it is intricately involved in the processes that mediate disease pathogenesis. Strategies that serve to alter PKC function may prove to be useful in the treatment of numerous disease states. This article reviews the various roles PKC may play in cardiovascular disease, specifically with regard to ischemic heart disease, cardiac hypertrophy, heart failure, hypertension, and atherosclerosis, and suggests the potential for developing therapeutic approaches that can target PKC activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596021     DOI: 10.1097/01.crd.0000124914.59755.8d

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  21 in total

1.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 2.  Proteomic technologies in the study of kinases: novel tools for the investigation of PKC in the heart.

Authors:  G Agnetti; L A Kane; C Guarnieri; C M Caldarera; J E Van Eyk
Journal:  Pharmacol Res       Date:  2007-05-03       Impact factor: 7.658

3.  PLCδ1 protein rescues ischemia-reperfused heart by the regulation of calcium homeostasis.

Authors:  Soyeon Lim; Woochul Chang; Min-Ji Cha; Byeong-Wook Song; Onju Ham; Se-Yeon Lee; Changyoun Lee; Jun-Hee Park; Sang-Kyou Lee; Yangsoo Jang; Ki-Chul Hwang
Journal:  Mol Ther       Date:  2014-03-18       Impact factor: 11.454

4.  PKCε promotes cardiac mitochondrial and metabolic adaptation to chronic hypobaric hypoxia by GSK3β inhibition.

Authors:  Joy McCarthy; Amanda Lochner; Lionel H Opie; Michael N Sack; M Faadiel Essop
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

5.  The effects of PKCalpha phosphorylation on the extensibility of titin's PEVK element.

Authors:  Brian R Anderson; Julius Bogomolovas; Siegfried Labeit; Henk Granzier
Journal:  J Struct Biol       Date:  2010-02-10       Impact factor: 2.867

6.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.

Authors:  D M Ouwens; C Boer; M Fodor; P de Galan; R J Heine; J A Maassen; M Diamant
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

7.  Excision of titin's cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness.

Authors:  Bryan D Hudson; Carlos G Hidalgo; Michael Gotthardt; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2009-12-21       Impact factor: 5.000

8.  Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.

Authors:  Janet R Manning; Sarah O Perkins; Elizabeth A Sinclair; Xiaoqian Gao; Yu Zhang; Gilbert Newman; W Glen Pyle; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

Review 9.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy.

Authors:  Gregor Simonis; Steffen K Briem; Steffen P Schoen; Manja Bock; Rainer Marquetant; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2007-06-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.